jnj-95475939
Small moleculeexperimental
Clinical trial activity
1 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 26, 2025 (NCT06881251)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Interleukin-31INHIBITOR
IL31 inhibitor
- Interleukin-4INHIBITOR
IL4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06881251 | Phase 2 | Feb 26, 2025 | — |
Showing 1 of 1 trials
Page 1 / 1